Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review (Q34465295)

2 August 2017

1 reference

title

Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review (English)

1 reference

2 August 2017

0 references

0 references

0 references

1 reference

1 reference

A Osella

6

0 references

Francesco Panza

object named as

F Panza

1

0 references

author name string

V Solfrizzi

2

1 reference

2 August 2017

M R Barulli

3

1 reference

2 August 2017

C Bonfiglio

4

1 reference

2 August 2017

V Guerra

5

1 reference

2 August 2017

D Seripa

7

1 reference

2 August 2017

C Sabbà

8

1 reference

2 August 2017

A Pilotto

9

1 reference

2 August 2017

G Logroscino

10

1 reference

2 August 2017

publication date

1 March 2015

1 reference

The Journal of Nutrition, Health and Aging

2 August 2017

published in

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

313-328

1 reference

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The epidemiology of the dementias: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The cell biology of Alzheimer's disease: uncovering the secrets of secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Diet and Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Fish, docosahexaenoic acid and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Dietary influences on cognitive function with aging: from high-fat diets to healthful eating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Alcohol, dementia and cognitive decline in the elderly: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Mediterranean diet, cognitive function, and dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The potential of caffeine for functional modification from cortical synapses to neuron networks in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee consumption and risk of stroke in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeinated clues from epidemiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Alzheimer's disease and coffee: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Does caffeine intake enhance absolute levels of cognitive performance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee consumption and cognitive function among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Vascular biomarkers of cognitive performance in a community-based elderly population: the Dublin Healthy Ageing study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine consumption and cognitive function at age 70: the Lothian Birth Cohort 1936 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The effects of habitual caffeine use on cognitive change: a longitudinal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The neuroprotective effects of caffeine: a prospective population study (the Three City Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee drinking in middle age is not associated with cognitive performance in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Tea drinking and cognitive function in oldest-old Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

A case-control study of Alzheimer's disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Does caffeine intake protect from Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Fruit and vegetable juices and Alzheimer's disease: the Kame Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Activation of adenosine A1 receptors in the nucleus accumbens impairs inhibitory avoidance memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Magnesium in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee, caffeine, and risk of depression among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Persistent increase in caffeine concentrations in people who stop smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Smoking patterns in a community sample of Portuguese adults, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee and health: a review of recent human research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Cardiovascular effects of coffee: is it a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers - results of German National Health Surveys from 1984 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Tea and cognitive health in late life: current evidence and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Beneficial effects of green tea--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Caffeine in tea Camellia sinensis--content, absorption, benefits and risks of consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Tea consumption and physical function in older adults: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Are we dependent upon coffee and caffeine? A review on human and animal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12603-014-0563-8

Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?

21 January 2018

1 reference

12 December 2020

Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases

1 reference

12 December 2020

Caffeine Synergizes with Another Coffee Component to Increase Plasma GCSF: Linkage to Cognitive Benefits in Alzheimer's Mice

1 reference

12 December 2020

Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline

1 reference

12 December 2020

Adenosine: does it have a neuroprotective role after all?

1 reference

12 December 2020

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice

1 reference

12 December 2020

The prevention of dementia

1 reference

12 December 2020

High Blood caffeine levels in MCI linked to lack of progression to dementia

1 reference

12 December 2020

Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk

1 reference

12 December 2020

Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal

1 reference

12 December 2020

Current epidemiological approaches to the metabolic-cognitive syndrome

1 reference

12 December 2020

Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats.

1 reference

12 December 2020

Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence.

1 reference

12 December 2020

2013 Alzheimer's disease facts and figures

1 reference

12 December 2020

Caffeine, diabetes, cognition, and dementia

1 reference

12 December 2020

Tea consumption and cognitive impairment and decline in older Chinese adults.

1 reference

12 December 2020

Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study

1 reference

12 December 2020

Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice

1 reference

12 December 2020

Mental disability among elderly men in Finland: prevalence, predictors and correlates

1 reference

12 December 2020

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

1 reference

12 December 2020

Dietary links to Alzheimer's disease: 1999 update.

1 reference

12 December 2020

Caffeine and cognitive decline in elderly women at high vascular risk

1 reference

12 December 2020

The role of diet in cognitive decline

1 reference

12 December 2020

Caffeine intake and dementia: systematic review and meta-analysis.

1 reference

12 December 2020

Caffeine, adenosine receptors, and synaptic plasticity

1 reference

12 December 2020

Vascular risk factors as treatment target to prevent cognitive decline

1 reference

12 December 2020

Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1.

1 reference

12 December 2020

Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?

1 reference

12 December 2020

Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial

1 reference

12 December 2020

Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans

1 reference

12 December 2020

Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates

1 reference

12 December 2020

Alzheimer's disease is incurable but preventable

1 reference

12 December 2020

10.1007/S12603-014-0563-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1034098165

0 references

1 reference